Conclusion: These studies reveal L1CAM expression level in endometrial cancer ranging from 7% to 44%, despite the same two antibody clones and 10% cutoff value almost always being used, raising questions about the preanalytical conditions and the pathologist’s interpretation, which probably impact results. The gene discussed is L1CAM; the disease is endometrial cancer.